ALPL Antikörper (AA 52-150) (Cy3)
Kurzübersicht für ALPL Antikörper (AA 52-150) (Cy3) (ABIN730991)
Target
Alle ALPL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 52-150
-
Kreuzreaktivität
- Human, Maus
-
Homologie
- Rat,Dog,Cow,Pig,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from AP-TNAP/ALPL
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- ALPL (Alkaline Phosphatase, Liver/bone/kidney (ALPL))
-
Andere Bezeichnung
- Ap-Tnap/Alpl
-
Hintergrund
-
Synonyms: Akp2, TNAP, Akp-2, APTNAP, TNSALP, Alkaline phosphatase, tissue-nonspecific isozyme, AP-TNAP, Alkaline phosphatase 2, Alkaline phosphatase liver/bone/kidney isozyme, Alpl
Background: Alkaline phosphatase (ALP) removes phosphate groups from the 5' end of DNA and RNA, and from proteins, at high pH . Most mammals have 4 different isozymes: placental, placental like, intestinal and non tissue specific (found in liver, kidney and bone). Tissues with particularly high concentrations of ALP include the liver, bile ducts, placenta, and bone. Damaged or diseased tissue releases enzymes into the blood, so serum ALP measurements can be abnormal in many conditions, including bone disease and liver disease.
-
Gen-ID
- 11647
-
UniProt
- P09242
Target
-